The SRI is frequently used to measure quality of life in severe COPD patients treated with NIV, but its MCID is unknown. This paper shows MCID estimates between 4.5–6.2, so that we suggest an increase of approximately 5 points is clinically relevant.https://bit.ly/3e0M7MT
No takes yet. Share an insight, caveat, or question.
Raveling et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: